Profile data is unavailable for this security.
About the company
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
- Revenue in USD (TTM)93.57m
- Net income in USD-68.01m
- Incorporated2015
- Employees330.00
- LocationAkoya Biosciences Inc100 Campus Drive, 6Th FloorMARLBOROUGH 01762United StatesUSA
- Phone+1 (415) 765-6980
- Websitehttps://www.akoyabio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Heartbeam Inc | 0.00 | -15.11m | 71.35m | 15.00 | -- | 5.69 | -- | -- | -0.6111 | -0.6111 | 0.00 | 0.4762 | 0.00 | -- | -- | 0.00 | -200.17 | -- | -258.74 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.94 | -- | -- | -- |
Hyperfine Inc | 11.69m | -41.93m | 72.87m | 131.00 | -- | 0.9634 | -- | 6.23 | -0.5858 | -0.5858 | 0.1633 | 1.05 | 0.1127 | 1.03 | 2.80 | 89,251.91 | -40.40 | -- | -43.95 | -- | 42.39 | -- | -358.59 | -- | 8.26 | -- | 0.00 | -- | 61.90 | -- | 39.54 | -- | -- | -- |
T2 Biosystems Inc | 7.18m | -45.65m | 77.60m | 113.00 | -- | -- | -- | 10.81 | -17.91 | -17.91 | 2.21 | -6.85 | 0.2497 | 3.24 | 4.93 | 63,504.43 | -158.80 | -106.01 | -- | -253.03 | -116.97 | -12.60 | -636.09 | -317.93 | 0.1936 | -- | 10.70 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
Myomo Inc | 19.55m | -9.34m | 81.26m | 101.00 | -- | 7.45 | -- | 4.16 | -0.2676 | -0.2676 | 0.5775 | 0.3786 | 1.29 | 3.23 | 12.10 | 193,552.80 | -61.73 | -81.78 | -89.94 | -115.27 | 67.39 | 68.50 | -47.77 | -85.76 | 2.40 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
Sensus Healthcare Inc | 31.66m | 4.65m | 83.11m | 35.00 | 17.78 | 1.62 | 16.88 | 2.63 | 0.2851 | 0.2851 | 1.94 | 3.12 | 0.5721 | 1.02 | 1.96 | 904,428.60 | 8.41 | 10.29 | 9.40 | 12.14 | 60.34 | 62.85 | 14.70 | 15.29 | 6.49 | -- | 0.00 | -- | -45.20 | -1.58 | -98.00 | -- | -23.16 | -- |
Xtant Medical Holdings Inc | 101.23m | -1.66m | 85.31m | 207.00 | -- | 1.79 | 41.70 | 0.8428 | -0.0189 | -0.0189 | 0.8019 | 0.3662 | 1.29 | 1.36 | 6.06 | 489,043.50 | -2.11 | -10.38 | -2.98 | -14.68 | 61.47 | 61.08 | -1.64 | -8.66 | 0.978 | -4.14 | 0.3638 | -- | 57.50 | 4.81 | 107.78 | -- | 18.47 | -- |
Asensus Surgical Inc | 8.72m | -78.71m | 91.43m | 207.00 | -- | 7.01 | -- | 10.48 | -0.3065 | -0.3065 | 0.0339 | 0.0479 | 0.1271 | 1.79 | 13.09 | 42,144.93 | -114.63 | -71.10 | -146.89 | -79.04 | -52.04 | -71.39 | -902.25 | -1,207.71 | 0.689 | -- | 0.00 | -- | 21.02 | -18.67 | -3.80 | -- | -6.14 | -- |
Akoya Biosciences Inc | 93.57m | -68.01m | 105.19m | 330.00 | -- | 3.21 | -- | 1.12 | -1.47 | -1.47 | 1.99 | 0.6632 | 0.6056 | 2.20 | 7.08 | 283,554.50 | -44.01 | -- | -56.06 | -- | 55.99 | -- | -72.68 | -- | 2.38 | -10.15 | 0.7013 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
TELA Bio Inc | 63.15m | -40.30m | 107.25m | 227.00 | -- | 7.46 | -- | 1.70 | -1.67 | -1.67 | 2.61 | 0.5834 | 0.9668 | 1.37 | 7.60 | 278,180.60 | -61.70 | -52.00 | -79.77 | -60.95 | 68.97 | 65.32 | -63.82 | -107.65 | 3.23 | -8.52 | 0.7387 | -- | 41.13 | 47.85 | -5.35 | -- | -17.12 | -- |
Fonar Corp | 102.72m | 10.29m | 107.74m | 561.00 | 10.84 | 0.65 | 5.71 | 1.05 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
EUDA Health Holdings Ltd | 3.71m | -8.44m | 114.52m | 106.00 | -- | -- | -- | 30.90 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
KORU Medical Systems Inc | 29.32m | -13.27m | 116.24m | 82.00 | -- | 6.07 | -- | 3.96 | -0.2905 | -0.2905 | 0.6422 | 0.4181 | 0.8919 | 2.38 | 6.85 | 357,595.80 | -40.35 | -17.60 | -47.06 | -20.29 | 60.24 | 59.44 | -45.24 | -21.70 | 3.37 | -- | 0.0284 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
Harvard Bioscience, Inc. | 106.79m | -8.73m | 120.30m | 391.00 | -- | 1.75 | -- | 1.13 | -0.2029 | -0.2029 | 2.50 | 1.58 | 0.7662 | 1.74 | 6.46 | 273,112.50 | -6.26 | -3.29 | -7.60 | -3.89 | 58.52 | 56.67 | -8.18 | -4.57 | 0.9352 | -0.4017 | 0.341 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
DIH Holding US Inc | 60.30m | -1.77m | 122.85m | -- | -- | -- | -- | 2.04 | -0.0435 | -0.0435 | 1.49 | -0.8079 | -- | -- | -- | -- | -- | -- | -- | -- | 60.18 | -- | -2.93 | -- | 0.2656 | 1.50 | -- | -- | 12.15 | -- | 80.41 | -- | -- | -- |
Electromed Inc | 53.50m | 4.36m | 126.55m | 170.00 | 29.58 | 2.97 | 24.44 | 2.37 | 0.4942 | 0.4942 | 6.08 | 4.92 | 1.17 | 3.31 | 2.25 | 314,682.30 | 9.49 | 7.86 | 11.03 | 9.14 | 76.41 | 76.25 | 8.14 | 7.38 | 5.87 | -- | 0.00 | 0.00 | 15.38 | 11.17 | 37.35 | 11.00 | 24.58 | -- |
Holder | Shares | % Held |
---|---|---|
Blue Water Life Science Advisors LPas of 31 Mar 2024 | 4.70m | 9.51% |
Polar Capital LLPas of 31 Mar 2024 | 1.58m | 3.20% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.41m | 2.86% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.20m | 2.44% |
Parkman Healthcare Partners LLCas of 31 Mar 2024 | 917.44k | 1.86% |
Uniplan Investment Counsel, Inc.as of 31 Mar 2024 | 699.84k | 1.42% |
Silvercrest Asset Management Group LLCas of 31 Mar 2024 | 580.83k | 1.18% |
SVB Wealth LLCas of 31 Mar 2024 | 515.32k | 1.04% |
Geode Capital Management LLCas of 31 Mar 2024 | 514.05k | 1.04% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 428.33k | 0.87% |